Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001838139-25-000010
Filing Date
2025-12-17
Accepted
2025-12-17 17:43:16
Documents
1
Period of Report
2025-12-16

Document Format Files

Seq Description Document Type Size
1 FORM 4 wk-form4_1766011394.html 4  
1 FORM 4 wk-form4_1766011394.xml 4 5705
  Complete submission text file 0001838139-25-000010.txt   7120
Mailing Address 110 EAST 59TH STREET NEW YORK NY 10022
Business Address 110 EAST 59TH STREET NEW YORK NY 10022 (212) 883-0200
Royalty Pharma plc (Issuer) CIK: 0001802768 (see all company filings)

EIN.: 000000000 | State of Incorp.: X0 | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)

Mailing Address C/O ROYALTY PHARMA PLC 110 EAST 59TH STREET NEW YORK NY 10022
Business Address
Urist Marshall (Reporting) CIK: 0001838139 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-39329 | Film No.: 251580437